ARTICLE | Company News
ReNeuron Ltd., StemCells deal
July 11, 2005 7:00 AM UTC
ReNeuron granted STEM exclusive access to its c-mycER adult human stem cell immortalization technology for use in developing therapies for lysosomal storage diseases, spinal cord injury, cerebral pals...